首页 > 最新文献

Journal of global antimicrobial resistance最新文献

英文 中文
Multiplex PCR pneumonia panel compared to standard culture of respiratory specimens: Retrospective results from a transplant centre 多重PCR肺炎组与标准培养呼吸道标本的比较:来自移植中心的回顾性结果。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-01 DOI: 10.1016/j.jgar.2025.12.004
Muhammad Sharjeel , Memoona Irshad , Azka Rizvi , Altaf Ahmed , Muhammad Jan Leghari

Objective

Rapid identification of lower respiratory tract infection pathogens is critical for initiating early antimicrobial therapy. This study aimed at evaluating the role of multiplex polymerase chain reaction (mPCR) in detecting respiratory pathogens and antimicrobial resistance at a transplant centre.

Methods

The study was a single-centre, retrospective analysis, completed at a tertiary care transplant centre. Data were included from 242 patients admitted with lower respiratory tract infection during a 24-month period. Respiratory specimens were analysed through BioFire PCR. Blood mPCR specimens were excluded (n = 44). Multiplex PCR results were compared with the gold standard of culture and sensitivity testing.

Results

A total of 198 patients were included in the study. The majority had a history of chronic hepatic or renal impairment (n = 95; 48%) or liver/kidney transplantation (n = 57; 28.8%). Chest imaging (n = 162) predominantly revealed pleural effusions (35.2%) and parenchymal infiltrates (28.4%). Most common sample types included sputum (n = 101; 51.0%) and tracheal aspirates (n = 93; 47.0%). Standard culture detected the following pathogens: 290 typical bacteria, 2 atypical organisms, and 95 viral detections. Klebsiella pneumoniae (32.3%) and Escherichia coli (28.8%) were most frequently identified. In n = 102 patients with corresponding culture results, mPCR had sensitivity of 76% and specificity of 59%, with 66.7% concordance between methods. Multiplex PCR and culture identified multiple bacterial species in 38 (37.3%) and 17 (16.7%) cases, respectively. Antimicrobial resistance gene analysis revealed high prevalence of CTX-M (30%), NDM (28%), and OXA-48-like (22%) mutations.

Conclusions

Multiplex PCR pneumonia panel demonstrated high sensitivity in detecting respiratory pathogens but had limitations in its specificity when compared to culture methods.
目的:快速识别下呼吸道感染(LRTI)病原体是启动早期抗菌治疗的关键。本研究旨在评估多重聚合酶链反应(mPCR)在移植中心检测呼吸道病原体和抗菌素耐药性(AMR)中的作用。方法:本研究为单中心回顾性分析,在三级保健移植中心完成。数据来自242例24个月内入院的LRTI患者。呼吸标本通过BioFire®PCR进行分析。排除血液mPCR标本(n=44)。将多重PCR结果与培养和敏感性试验金标准进行比较。结果:纳入n=198例患者的数据。大多数患者有慢性肝肾损害史(n=95, 48%)或肝/肾移植史(n=57, 28.8%)。胸部显像(n=162)主要显示胸腔积液(35.2%)和实质浸润(28.4%)。最常见的样本类型包括痰液(n=101, 51.0%)和气管吸入物(n=93, 47.0%)。病原菌检测结果如下:典型菌290例,非典型菌2例,病毒95例。肺炎克雷伯菌(32.3%)和大肠埃希菌(28.8%)最为常见。在n=102例有相应培养结果的患者中,mPCR的敏感性为76%,特异性为59%,两种方法的一致性为66.7%。多重PCR和培养分别检出38例(37.3%)和17例(16.7%)多菌种。AMR基因分析显示CTX-M(30%)、NDM(28%)和oxa -48样(22%)突变的高患病率。结论:多重PCR肺炎检测方法对呼吸道病原菌的检测具有较高的敏感性,但与培养方法相比,其特异性存在局限性。
{"title":"Multiplex PCR pneumonia panel compared to standard culture of respiratory specimens: Retrospective results from a transplant centre","authors":"Muhammad Sharjeel ,&nbsp;Memoona Irshad ,&nbsp;Azka Rizvi ,&nbsp;Altaf Ahmed ,&nbsp;Muhammad Jan Leghari","doi":"10.1016/j.jgar.2025.12.004","DOIUrl":"10.1016/j.jgar.2025.12.004","url":null,"abstract":"<div><h3>Objective</h3><div>Rapid identification of lower respiratory tract infection pathogens is critical for initiating early antimicrobial therapy. This study aimed at evaluating the role of multiplex polymerase chain reaction (mPCR) in detecting respiratory pathogens and antimicrobial resistance at a transplant centre.</div></div><div><h3>Methods</h3><div>The study was a single-centre, retrospective analysis, completed at a tertiary care transplant centre. Data were included from 242 patients admitted with lower respiratory tract infection during a 24-month period. Respiratory specimens were analysed through BioFire PCR. Blood mPCR specimens were excluded (<em>n</em> = 44). Multiplex PCR results were compared with the gold standard of culture and sensitivity testing.</div></div><div><h3>Results</h3><div>A total of 198 patients were included in the study. The majority had a history of chronic hepatic or renal impairment (<em>n</em> = 95; 48%) or liver/kidney transplantation (<em>n</em> = 57; 28.8%). Chest imaging (<em>n</em> = 162) predominantly revealed pleural effusions (35.2%) and parenchymal infiltrates (28.4%). Most common sample types included sputum (<em>n</em> = 101; 51.0%) and tracheal aspirates (<em>n</em> = 93; 47.0%). Standard culture detected the following pathogens: 290 typical bacteria, 2 atypical organisms, and 95 viral detections. <em>Klebsiella pneumoniae</em> (32.3%) and <em>Escherichia coli</em> (28.8%) were most frequently identified. In <em>n</em> = 102 patients with corresponding culture results, mPCR had sensitivity of 76% and specificity of 59%, with 66.7% concordance between methods. Multiplex PCR and culture identified multiple bacterial species in 38 (37.3%) and 17 (16.7%) cases, respectively. Antimicrobial resistance gene analysis revealed high prevalence of CTX-M (30%), NDM (28%), and OXA-48-like (22%) mutations.</div></div><div><h3>Conclusions</h3><div>Multiplex PCR pneumonia panel demonstrated high sensitivity in detecting respiratory pathogens but had limitations in its specificity when compared to culture methods.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"46 ","pages":"Pages 179-186"},"PeriodicalIF":3.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145723937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genomic insights into a multidrug-resistant uropathogenic Escherichia coli ST131-H30 strain associated with a fatal healthcare-associated infection 多药耐药尿路致病性大肠杆菌ST131-H30菌株与致命医疗保健相关感染的基因组分析
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-01 DOI: 10.1016/j.jgar.2025.12.008
Samara Sant’Anna de Oliveira , Camille Alves Brito de Moura , Kaylanne Montenegro , Thereza Cristina da Costa Vianna , Ana Paula Alves do Nascimento , Gerson Gatto de Azeredo Coutinho , Hosana Dau Ferreira de Souza , Claudia Gladys Flores Sejas , Alexander Machado Cardoso , Kayo Bianco , Maysa Mandetta Clementino

Objective

Uropathogenic Escherichia coli (UPEC) poses a significant public health challenge due to increasing antimicrobial resistance (AMR) and severe infections. This study aimed to investigate the genetic heterogeneity and AMR mechanisms of a clinical UPEC strain associated with a fatal healthcare-associated infection.

Methods

Whole-genome sequencing (WGS) was performed on a multidrug-resistant (MDR) UPEC strain isolated from a pediatric patient by using an Illumina Miseq platform. The genome was assembled using Unicycler v0.4.8 and was annotated using the NCBI Prokaryotic Genome Annotation Pipeline (PGAP). Genomic analysis included characterisation of the resistome, virulome, and phylogenetic profile using various bioinformatics tools such as ResFinder v4.7.2, VFDB, and PubMLST.

Results

The isolate has a genome with a size of 4,681,240 bp, a GC content of 50.60% and harbour seven plasmids. Genomic analysis revealed multiple genetic determinants contributing to a multidrug-resistant profile, including efflux systems, enzymatic target alterations, and antibiotic transporter modifications. Adhesin genes (fimH, afaA-D, lpfA, fdeC, csgA), hemolysins (hlyE, hlyF), iron acquisition systems (iucC, iutA, sitA), and genes related to antimicrobial peptide degradation (ompT, traJ) and colicin production (cma, cvaC) were identified. Resistance to heavy metals (tellurium, copper/silver, arsenic) was also detected. These findings characterise the isolate as a highly virulent, multidrug-resistant, and environmentally resilient emerging UPEC clone.

Conclusions

This study highlights the convergence of virulence, AMR, and environmental adaptability in an ST131-H30 UPEC strain. The findings underscore the critical need for comprehensive genomic surveillance, infection control strategies to mitigate the public health impact of MDR E. coli.
目的:。尿路致病性大肠杆菌(UPEC)由于抗菌素耐药性(AMR)和严重感染的增加而对公共卫生构成重大挑战。本研究旨在探讨与致命性医疗保健相关感染相关的临床UPEC菌株的遗传异质性和AMR机制。方法:。使用Illumina Miseq平台对从一名儿科患者分离的多药耐药(MDR) UPEC菌株进行全基因组测序(WGS)。使用Unicycler v0.4.8进行基因组组装,并使用NCBI原核基因组注释管道(PGAP)进行注释。基因组分析包括使用各种生物信息学工具(如ResFinder v4.7.2、VFDB和PubMLST)对抗性组、病毒组和系统发育谱进行表征。结果:。该分离物基因组大小为4,681,240 bp, GC含量为50.60%,含有7个质粒。基因组分析显示,多种遗传决定因素导致多药耐药,包括外排系统、酶靶改变和抗生素转运蛋白修饰。粘附素基因(fimH, afaA-D, lpfA, fdeC, csgA),溶血素基因(hye, hlyF),铁获取系统(iucC, iutA, sitA)以及抗菌肽降解相关基因(ompT, traJ)和粘菌素产生相关基因(cma, cvaC)被鉴定出来。对重金属(碲、铜/银、砷)的抗性也被检测到。这些发现将该分离物定性为高毒力、多药耐药和环境适应性强的新兴UPEC克隆。结论:。本研究强调了ST131-H30 UPEC菌株的毒力、抗菌素耐药性和环境适应性的趋同。这些发现强调了全面的基因组监测和感染控制战略的迫切需要,以减轻耐多药大肠杆菌对公共卫生的影响。
{"title":"Genomic insights into a multidrug-resistant uropathogenic Escherichia coli ST131-H30 strain associated with a fatal healthcare-associated infection","authors":"Samara Sant’Anna de Oliveira ,&nbsp;Camille Alves Brito de Moura ,&nbsp;Kaylanne Montenegro ,&nbsp;Thereza Cristina da Costa Vianna ,&nbsp;Ana Paula Alves do Nascimento ,&nbsp;Gerson Gatto de Azeredo Coutinho ,&nbsp;Hosana Dau Ferreira de Souza ,&nbsp;Claudia Gladys Flores Sejas ,&nbsp;Alexander Machado Cardoso ,&nbsp;Kayo Bianco ,&nbsp;Maysa Mandetta Clementino","doi":"10.1016/j.jgar.2025.12.008","DOIUrl":"10.1016/j.jgar.2025.12.008","url":null,"abstract":"<div><h3>Objective</h3><div>Uropathogenic Escherichia coli (UPEC) poses a significant public health challenge due to increasing antimicrobial resistance (AMR) and severe infections. This study aimed to investigate the genetic heterogeneity and AMR mechanisms of a clinical UPEC strain associated with a fatal healthcare-associated infection.</div></div><div><h3>Methods</h3><div>Whole-genome sequencing (WGS) was performed on a multidrug-resistant (MDR) UPEC strain isolated from a pediatric patient by using an Illumina Miseq platform. The genome was assembled using Unicycler v0.4.8 and was annotated using the NCBI Prokaryotic Genome Annotation Pipeline (PGAP). Genomic analysis included characterisation of the resistome, virulome, and phylogenetic profile using various bioinformatics tools such as ResFinder v4.7.2, VFDB, and PubMLST.</div></div><div><h3>Results</h3><div>The isolate has a genome with a size of 4,681,240 bp, a GC content of 50.60% and harbour seven plasmids. Genomic analysis revealed multiple genetic determinants contributing to a multidrug-resistant profile, including efflux systems, enzymatic target alterations, and antibiotic transporter modifications. Adhesin genes (fimH, afaA-D, lpfA, fdeC, csgA), hemolysins (hlyE, hlyF), iron acquisition systems (iucC, iutA, sitA), and genes related to antimicrobial peptide degradation (ompT, traJ) and colicin production (cma, cvaC) were identified. Resistance to heavy metals (tellurium, copper/silver, arsenic) was also detected. These findings characterise the isolate as a highly virulent, multidrug-resistant, and environmentally resilient emerging UPEC clone.</div></div><div><h3>Conclusions</h3><div>This study highlights the convergence of virulence, AMR, and environmental adaptability in an ST131-H30 UPEC strain. The findings underscore the critical need for comprehensive genomic surveillance, infection control strategies to mitigate the public health impact of MDR <em>E. coli.</em></div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"46 ","pages":"Pages 175-178"},"PeriodicalIF":3.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145774901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genomic analysis of a novel high-risk ST5217/ExoU+/O11 clone of carbapenem-resistant OXA-181- and VIM-2-producing Pseudomonas aeruginosa in India 耐碳青霉烯OXA-181-和产vim -2铜绿假单胞菌新型高风险ST5217/ExoU+/O11克隆的基因组分析
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-01 DOI: 10.1016/j.jgar.2025.12.002
Subhasree Roy , Souvik Nandy , Daichi Morita , Ranjan Kumar Nandy , Balaji Veeraraghavan , Kamini Walia , Santasabuj Das , Sulagna Basu

Objectives

Studies of carbapenem-resistant Pseudomonas aeruginosa (CRPA)-harbouring OXA-48-like carbapenemases are rare. The study aimed to report the emergence and characterization of a novel high-risk clone of CRPA-harbouring OXA-48-like from India.

Methods

Identification, AST, phenotypic detection of carbapenemases and WGS using Ion-Torrent-S5 platform were carried out. Analyses included ResFinder, VFDB, MLST, PAst, Phastest and CRISPR/Cas. SNP-based phylogenetic analysis with global OXA-48-like-harbouring CRPA genomes was carried out by CSI Phylogeny and iTOL for visualization.

Results

The clinical MDR strain of CRPA AMRIR00655 belonged to a novel sequence type ST5217 and serotype O11. Phenotypic tests followed by WGS revealed the presence of dual carbapenemases, OXA-181 (serine-carbapenemase) and VIM-2 (zinc-carbapenemase), both located on chromosome. blaOXA-181 resides between chromosomal genes encoding RodZ and PAP2 in P. aeruginosa, confirming chromosomal integration.4,261 bp of blaOXA-181-bearing contig-DNA showed 100% homology to K. pneumoniae plasmid pKP3-A. ISEcp1 was present on upstream and on downstream, △lysR,ereA and repA genes were detected. blaVIM-2 was located within class 1 integron along with aacC6-II, dfrB5, aac(3)-Id, tniC in surrounding regions and 13,242 bp showing 100% identity to P. aeruginosa chromosome. Presence of other ARGs (blaPAO, blaOXA-488, aph(3′')-Ib, aph(6)-Id, crpP, catB7, fosA, sul2) and efflux-pump genes might explain its MDR phenotype. Virulence factors including T3SS (PscF, PopB, PopD, PcrV) and its effectors (ExoT, ExoU, ExoY) indicated the pathogenic potential of ST5217. Core genome analysis showed that ST5217 was closest with other high-risk clones ST1339 and ST773-harbouring blaOXA-48-like.

Conclusions

To the best of our knowledge, this is the first report of blaOXA-181-harbouring novel high-risk clone of CRPA ST5217/ExoU+/O11 in India which emphasises the spread of OXA-181 among bacteria other than Enterobacteriaceae-family and warrant close monitoring.
目的:碳青霉烯耐药铜绿假单胞菌(CRPA)-窝藏oxa -48样碳青霉烯酶的研究很少见。该研究旨在报道一种来自印度的含有crpa的oxa -48样的新型高风险克隆的出现和特征。方法:采用Ion-Torrent-S5平台对碳青霉烯酶和WGS进行鉴定、AST、表型检测。分析包括ResFinder、VFDB、MLST、PAst、Phastest和CRISPR/Cas。利用CSI Phylogeny和iTOL进行基于snp的全球oxa -48样窝藏CRPA基因组系统发育分析。结果:CRPA AMRIR00655临床菌株属于ST5217新序列型和O11血清型。该菌株是耐多药耐药菌株。表型检测后的WGS显示存在双碳青霉烯酶,OXA-181(丝氨酸碳青霉烯酶)和VIM-2(锌碳青霉烯酶),均位于染色体上。4261 bp的blaoxa -181序列dna与肺炎克雷伯菌质粒pKP3-A同源性100%。ISEcp1存在于上游和下游,检测到△lysR、△ereA和repA基因。blaVIM-2与周边区域的aacC6-II、dfrB5、aac(3)-Id、tniC位于1类整合子内。其他ARGs (blaPAO, blaOXA-488,aph(3'')-Ib, aph(6)-Id, crpP, catB7, fosA, sul2)和外排泵基因的存在可能解释其MDR表型。毒力因子包括T3SS (PscF、PopB、PopD、PcrV)及其效应物(ExoT、ExoU、ExoY),表明ST5217具有致病潜力。核心基因组分析显示,ST5217与其他携带blaoxa -48样的高风险克隆ST1339和st773最接近。结论:据我们所知,这是印度首次报道携带OXA-181的新型CRPA ST5217/ExoU+/O11高风险克隆,强调OXA-181在肠杆菌科以外的细菌中传播,需要密切监测。
{"title":"Genomic analysis of a novel high-risk ST5217/ExoU+/O11 clone of carbapenem-resistant OXA-181- and VIM-2-producing Pseudomonas aeruginosa in India","authors":"Subhasree Roy ,&nbsp;Souvik Nandy ,&nbsp;Daichi Morita ,&nbsp;Ranjan Kumar Nandy ,&nbsp;Balaji Veeraraghavan ,&nbsp;Kamini Walia ,&nbsp;Santasabuj Das ,&nbsp;Sulagna Basu","doi":"10.1016/j.jgar.2025.12.002","DOIUrl":"10.1016/j.jgar.2025.12.002","url":null,"abstract":"<div><h3>Objectives</h3><div>Studies of carbapenem-resistant <em>Pseudomonas aeruginosa</em> (CRPA)-harbouring OXA-48-like carbapenemases are rare. The study aimed to report the emergence and characterization of a novel high-risk clone of CRPA-harbouring OXA-48-like from India.</div></div><div><h3>Methods</h3><div>Identification, AST, phenotypic detection of carbapenemases and WGS using Ion-Torrent-S5 platform were carried out. Analyses included ResFinder, VFDB, MLST, PAst, Phastest and CRISPR/Cas. SNP-based phylogenetic analysis with global OXA-48-like-harbouring CRPA genomes was carried out by CSI Phylogeny and iTOL for visualization.</div></div><div><h3>Results</h3><div>The clinical MDR strain of CRPA AMRIR00655 belonged to a novel sequence type ST5217 and serotype O11. Phenotypic tests followed by WGS revealed the presence of dual carbapenemases, OXA-181 (serine-carbapenemase) and VIM-2 (zinc-carbapenemase), both located on chromosome. <em>bla</em><sub>OXA-181</sub> resides between chromosomal genes encoding RodZ and PAP2 in <em>P. aeruginosa</em>, confirming chromosomal integration<em>.</em>4,261 bp of <em>bla</em><sub>OXA-181</sub>-bearing contig-DNA showed 100% homology to <em>K. pneumoniae</em> plasmid pKP3-A. IS<em>Ecp1</em> was present on upstream and on downstream, △<em>lysR,</em> △<em>ereA</em> and <em>repA</em> genes were detected. <em>bla</em><sub>VIM-2</sub> was located within class 1 integron along with <em>aacC6-II, dfrB5, aac(3)-Id, tniC</em> in surrounding regions and 13,242 bp showing 100% identity to <em>P. aeruginosa</em> chromosome. Presence of other ARGs (<em>bla</em><sub>PAO</sub>, <em>bla</em><sub>OXA-488,</sub> <em>aph(3′')-Ib, aph(6)-Id, crpP, catB7, fosA, sul2</em>) and efflux-pump genes might explain its MDR phenotype. Virulence factors including T3SS (PscF, PopB, PopD, PcrV) and its effectors (ExoT, ExoU, ExoY) indicated the pathogenic potential of ST5217. Core genome analysis showed that ST5217 was closest with other high-risk clones ST1339 and ST773-harbouring <em>bla</em><sub>OXA-48-like</sub>.</div></div><div><h3>Conclusions</h3><div>To the best of our knowledge, this is the first report of <em>bla</em><sub>OXA-181</sub>-harbouring novel high-risk clone of CRPA ST5217/ExoU+/O11 in India which emphasises the spread of OXA-181 among bacteria other than Enterobacteriaceae-family and warrant close monitoring.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"46 ","pages":"Pages 158-161"},"PeriodicalIF":3.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145742985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrative machine learning approaches with genomic data for predicting antitubercular drug resistance: A systematic review and meta-analysis 整合机器学习方法与基因组数据预测抗结核药物耐药性:系统回顾和荟萃分析。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-01 DOI: 10.1016/j.jgar.2025.11.021
Rohan Shrivastava , Kashmi Sharma , Somesh Mishra , Poonam Parihar , Gobardhan Das , Khushhali Menaria Pandey , Anand Kumar Maurya , Vineet Kumar Sharma , Anamika Mishra , Sandeep Kushwaha , Rekha Khandia , Kuldeep Singh Yadav , Anvita Gupta Malhotra , Amit Agrawal , Jitendra Singh , Megha Katare Pandey

Objectives

Tuberculosis (TB) remains a leading infectious cause of death, with drug-resistant TB threatening control gains worldwide Rapid, accurate prediction of resistance to first-line agents is essential to guide therapy.
The objective of this meta-analysis is to evaluate the diagnostic performance of machine learning (ML) algorithms trained on genomic data for predicting phenotypic resistance to the antitubercular drugs.

Methods

We searched 4 databases for original studies applying ML to whole-genome or targeted sequencing for resistance prediction against rifampicin (RIF), isoniazid (INH), ethambutol (EMB), streptomycin (STM), and other routinely tested drugs. Random-effects meta-analyses (REML) pooled sensitivity and specificity; Area Under Curve (AUC) was meta-analysed after logit transformation. Publication bias was examined via funnel plots plus Egger’s and Begg’s tests with trim-and-fill adjustment.

Results

Seven eligible studies were included. Pooled performance was strongest for RIF and INH (RIF: sensitivity 0.90, specificity 0.95; INH: sensitivity 0.88, specificity 0.93). EMB and STM showed lower sensitivities despite reasonable AUCs. Forest plots for AUC (including logit scale), sensitivity, and specificity demonstrated drug-wise variation. Across studies, specificity (mean ≈ 0.92) exceeded sensitivity (mean ≈ 0.75). Bias diagnostics revealed marked funnel plot asymmetry; trim-and-fill imputation added 22, 29, and 23 studies for AUC, sensitivity, and specificity, respectively, yielding adjusted pooled estimates of ∼0.89 (AUC), 0.70 (sensitivity), and 0.93 (specificity).

Conclusions

ML models trained on genomic data demonstrate high diagnostic accuracy and robust discriminative ability for predicting first-line drug resistance—particularly for RIF and INH—although sensitivity remains variable across drugs and model types. Standardized external validation and calibration are needed before broad clinical deployment.
目的:结核病(TB)仍然是主要的传染性死亡原因,耐药结核病威胁着世界范围内的控制成果,快速、准确地预测对一线药物的耐药性对于指导治疗至关重要。本荟萃分析的目的是评估基于基因组数据训练的机器学习(ML)算法的诊断性能,以预测抗结核药物的表型耐药性。方法:我们检索了4个数据库,检索了应用ML全基因组或靶向测序预测对利福平(RIF)、异烟肼(INH)、乙胺丁醇(EMB)、链霉素(STM)和其他常规检测药物耐药的原始研究。随机效应荟萃分析(REML)汇集了敏感性和特异性;曲线下面积(AUC)经logit变换后进行meta分析。发表偏倚通过漏斗图和Egger’s和Begg’s检验进行检验。结果:纳入了7项符合条件的研究。RIF和INH的综合表现最强(RIF:敏感性0.90,特异性0.95;INH:敏感性0.88,特异性0.93)。尽管auc合理,但EMB和STM的敏感性较低。AUC(包括logit量表)、敏感性和特异性的森林图显示了药物方面的差异。在所有研究中,特异性(平均值≈0.92)超过敏感性(平均值≈0.75)。偏倚诊断显示漏斗图不对称性明显;修整填充法分别增加了22、29和23项AUC、敏感性和特异性研究,调整后的合并估计值分别为0.89 (AUC)、0.70(敏感性)和0.93(特异性)。结论:基于基因组数据训练的ML模型在预测一线耐药性(尤其是RIF和inh)方面表现出较高的诊断准确性和强大的判别能力,尽管敏感性在药物和模型类型之间仍然存在差异。在广泛的临床部署之前,需要标准化的外部验证和校准。
{"title":"Integrative machine learning approaches with genomic data for predicting antitubercular drug resistance: A systematic review and meta-analysis","authors":"Rohan Shrivastava ,&nbsp;Kashmi Sharma ,&nbsp;Somesh Mishra ,&nbsp;Poonam Parihar ,&nbsp;Gobardhan Das ,&nbsp;Khushhali Menaria Pandey ,&nbsp;Anand Kumar Maurya ,&nbsp;Vineet Kumar Sharma ,&nbsp;Anamika Mishra ,&nbsp;Sandeep Kushwaha ,&nbsp;Rekha Khandia ,&nbsp;Kuldeep Singh Yadav ,&nbsp;Anvita Gupta Malhotra ,&nbsp;Amit Agrawal ,&nbsp;Jitendra Singh ,&nbsp;Megha Katare Pandey","doi":"10.1016/j.jgar.2025.11.021","DOIUrl":"10.1016/j.jgar.2025.11.021","url":null,"abstract":"<div><h3>Objectives</h3><div>Tuberculosis (TB) remains a leading infectious cause of death, with drug-resistant TB threatening control gains worldwide Rapid, accurate prediction of resistance to first-line agents is essential to guide therapy.</div><div>The objective of this meta-analysis is to evaluate the diagnostic performance of machine learning (ML) algorithms trained on genomic data for predicting phenotypic resistance to the antitubercular drugs.</div></div><div><h3>Methods</h3><div>We searched 4 databases for original studies applying ML to whole-genome or targeted sequencing for resistance prediction against rifampicin (RIF), isoniazid (INH), ethambutol (EMB), streptomycin (STM), and other routinely tested drugs. Random-effects meta-analyses (REML) pooled sensitivity and specificity; Area Under Curve (AUC) was meta-analysed after logit transformation. Publication bias was examined via funnel plots plus Egger’s and Begg’s tests with trim-and-fill adjustment.</div></div><div><h3>Results</h3><div>Seven eligible studies were included. Pooled performance was strongest for RIF and INH (RIF: sensitivity 0.90, specificity 0.95; INH: sensitivity 0.88, specificity 0.93). EMB and STM showed lower sensitivities despite reasonable AUCs. Forest plots for AUC (including logit scale), sensitivity, and specificity demonstrated drug-wise variation. Across studies, specificity (mean ≈ 0.92) exceeded sensitivity (mean ≈ 0.75). Bias diagnostics revealed marked funnel plot asymmetry; trim-and-fill imputation added 22, 29, and 23 studies for AUC, sensitivity, and specificity, respectively, yielding adjusted pooled estimates of ∼0.89 (AUC), 0.70 (sensitivity), and 0.93 (specificity).</div></div><div><h3>Conclusions</h3><div>ML models trained on genomic data demonstrate high diagnostic accuracy and robust discriminative ability for predicting first-line drug resistance—particularly for RIF and INH—although sensitivity remains variable across drugs and model types. Standardized external validation and calibration are needed before broad clinical deployment.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"46 ","pages":"Pages 148-157"},"PeriodicalIF":3.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145756841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global prediction of antimicrobial resistance trends using statistical and machine learning models: Evaluating national action plan policy impacts through interrupted time series analysis 使用统计和机器学习模型预测抗菌素耐药性趋势:通过中断时间序列分析评估国家行动计划政策影响。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-01 DOI: 10.1016/j.jgar.2025.11.022
Linta Khalid , Kashif Saleem , Saima Mushtaq , Iltaf Hussain , Zamir Hussain , Zainab Hussain , Rehan Zafar Paracha , Amjad Khan , Jie Chang , Yu Fang , Imran Sajid

Objective

Antimicrobial resistance (AMR) is a pressing global health challenge, particularly affecting low- and middle-income countries. This study aims to evaluate the spread of AMR both across time and across different regions of the world.

Methods

We analysed clinical isolates from 65 countries. A country-specific time-series forecasting (i.e. seasonal autoregressive integrated moving average (SARIMA), long short-term memory (LSTM), and seasonal autoregressive integrated moving average-LSTM hybrid models) were performed for Acinetobacter baumannii in Argentina (2004–2030) as a case study to demonstrate model applicability for national-level prediction. Moreover, interrupted time series regression was applied to predict antibiotic-resistance trends and assess the global impact of national action plans.

Results

Southeast Asia and Africa exhibited the highest AMR burdens, with Indonesia (0.65), Egypt (0.52), and Malawi (0.49) having the highest resistance scores. An income-based gradient was observed across key pathogens, third-generation cephalosporin and carbapenem-resistant Escherichia coli, Klebsiella pneumoniae, and A. baumannii were significantly more prevalent in low- and middle-income countries. Gender-wise analysis revealed significantly higher resistance rates in males across most antibiotics, especially levofloxacin. Age-stratified analyses revealed higher resistance in elderly populations, particularly to fluoroquinolones and β-lactams. Forecasting for A. baumannii in Argentina (2004–2030) indicated a continued upward resistance across β-lactam and fluoroquinolones, with LSTM achieving the lowest root mean square error across five antibiotics. The interrupted time series revealed a prenational action plan decline but no significant postimplementation change.

Conclusion

This study provides a comprehensive data-driven framework to monitor and forecast AMR, evaluate policy interventions, and, hence, suggest targeted interventions and strategies for each income group and region, moving beyond the one-size-fits-all approach.
目标:抗微生物药物耐药性(AMR)是一项紧迫的全球卫生挑战,尤其影响到低收入和中等收入国家。本研究旨在评估抗菌素耐药性在不同时间和不同地区的传播情况。方法:对来自65个国家的临床分离株进行分析。在阿根廷(2004-2030年)对鲍曼不动杆菌进行国别时间序列预测,即SARIMA、LSTM和SARIMA-LSTM混合模型,作为一个案例研究,以证明模型在国家级预测中的适用性。此外,中断时间序列(ITS)回归应用于预测抗生素耐药性趋势和评估国家行动计划(nap)的全球影响。结果:东南亚和非洲的抗菌素耐药性负担最高,耐药评分最高的是印度尼西亚(0.65)、埃及(0.52)和马拉维(0.49)。在主要病原体中观察到基于收入的梯度,第三代头孢菌素和碳青霉烯耐药大肠埃希菌、肺炎克雷伯菌和鲍曼不动杆菌在低收入国家中更为普遍。性别分析显示,男性对大多数抗生素的耐药率明显较高,尤其是左氧氟沙星。年龄分层分析显示,老年人对氟喹诺酮类药物和β-内酰胺类药物的耐药性更高。对阿根廷(2004-2030年)鲍曼不均匀杆菌的预测表明,对β-内酰胺类药物和氟喹诺酮类药物的耐药性持续上升,LSTM在五种抗生素中达到最低的RMSE。ITS显示nap实施前的下降,但实施后没有明显变化。结论:本研究提供了一个全面的数据驱动框架,用于监测和预测抗菌素耐药性,评估政策干预措施,从而为每个收入群体和地区提出有针对性的干预措施和战略,超越“一刀切”的做法。
{"title":"Global prediction of antimicrobial resistance trends using statistical and machine learning models: Evaluating national action plan policy impacts through interrupted time series analysis","authors":"Linta Khalid ,&nbsp;Kashif Saleem ,&nbsp;Saima Mushtaq ,&nbsp;Iltaf Hussain ,&nbsp;Zamir Hussain ,&nbsp;Zainab Hussain ,&nbsp;Rehan Zafar Paracha ,&nbsp;Amjad Khan ,&nbsp;Jie Chang ,&nbsp;Yu Fang ,&nbsp;Imran Sajid","doi":"10.1016/j.jgar.2025.11.022","DOIUrl":"10.1016/j.jgar.2025.11.022","url":null,"abstract":"<div><h3>Objective</h3><div>Antimicrobial resistance (AMR) is a pressing global health challenge, particularly affecting low- and middle-income countries. This study aims to evaluate the spread of AMR both across time and across different regions of the world.</div></div><div><h3>Methods</h3><div>We analysed clinical isolates from 65 countries. A country-specific time-series forecasting (i.e. seasonal autoregressive integrated moving average (SARIMA), long short-term memory (LSTM), and seasonal autoregressive integrated moving average-LSTM hybrid models) were performed for <em>Acinetobacter baumannii</em> in Argentina (2004–2030) as a case study to demonstrate model applicability for national-level prediction. Moreover, interrupted time series regression was applied to predict antibiotic-resistance trends and assess the global impact of national action plans.</div></div><div><h3>Results</h3><div>Southeast Asia and Africa exhibited the highest AMR burdens, with Indonesia (0.65), Egypt (0.52), and Malawi (0.49) having the highest resistance scores. An income-based gradient was observed across key pathogens, third-generation cephalosporin and carbapenem-resistant <em>Escherichia coli, Klebsiella pneumoniae</em>, and <em>A. baumannii</em> were significantly more prevalent in low- and middle-income countries. Gender-wise analysis revealed significantly higher resistance rates in males across most antibiotics, especially levofloxacin. Age-stratified analyses revealed higher resistance in elderly populations, particularly to fluoroquinolones and β-lactams. Forecasting for <em>A. baumannii</em> in Argentina (2004–2030) indicated a continued upward resistance across β-lactam and fluoroquinolones, with LSTM achieving the lowest root mean square error across five antibiotics. The interrupted time series revealed a prenational action plan decline but no significant postimplementation change.</div></div><div><h3>Conclusion</h3><div>This study provides a comprehensive data-driven framework to monitor and forecast AMR, evaluate policy interventions, and, hence, suggest targeted interventions and strategies for each income group and region, moving beyond the one-size-fits-all approach.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"46 ","pages":"Pages 214-226"},"PeriodicalIF":3.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145800582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vitro activity of vancomycin and other commonly used Antibiotics against clinical isolates of Enterococcus faecalis and Enterococcus faecium: Data from the antimicrobial testing leadership and surveillance (ATLAS) program from 2019 to 2023 万古霉素和其他常用抗生素对粪肠球菌和粪肠球菌临床分离株的体外活性:来自2019 - 2023年抗菌测试领导和监测(ATLAS)计划的数据
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-01 DOI: 10.1016/j.jgar.2025.12.018
Yu Liu , Xu Zheng , Binwei Wu

Objectives

Enterococci are significant hospital pathogens, posing a serious global public health threat. This study aimed to analyze the in vitro susceptibility of enterococcal isolates to eight commonly used antibiotics and to explore cross-resistance patterns in vancomycin-resistant enterococci (VRE), including their heterogeneity across geographic regions, clinical wards, and infection sites.

Methods

Utilizing data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program (2019–2023), this study analyzed 18,043 enterococcal isolates (12,007 Enterococcus faecalis and 6,036 Enterococcus faecium) from 59 countries across six continents. We assessed in vitro susceptibility to eight common antibiotics and evaluated VRE cross-resistance patterns.

Results

: E. faecalis showed susceptibility rates greater than 95% to ampicillin, daptomycin, linezolid, teicoplanin, tigecycline, and vancomycin. In contrast, E. faecium exhibited susceptibility greater than 90% only for linezolid and tigecycline. The vancomycin resistance rate in E. faecium was 25.4%, significantly higher than in E. faecalis (1.22%), with notable multidrug cross-resistance. Geographically, North America displayed the highest vancomycin resistance rate in E. faecium (53.25%), while Asia showed the highest linezolid resistance rate in this species (2.9%). ICU and non-pediatric patients generally exhibited higher resistance rates, and genitourinary specimens showed slightly higher resistance than those from other sites.

Conclusions

Enterococcal resistance varies significantly across species, regions, and clinical environments. The extensive cross-resistance in VRE poses a major challenge to clinical treatment. Tigecycline and linezolid remain highly effective in vitro globally. To slow the spread of resistant strains, it is crucial to enhance resistance monitoring in high-risk regions and populations, while optimizing antibiotic usage strategies.
目的:肠球菌是一种重要的医院病原体,对全球公共卫生构成严重威胁。本研究旨在分析肠球菌分离物对8种常用抗生素的体外敏感性,并探讨万古霉素耐药肠球菌(VRE)的交叉耐药模式,包括其在地理区域、临床病房和感染部位的异质性。方法:利用ATLAS项目(2019-2023)的数据,对来自六大洲59个国家的18043株肠球菌(12,007株粪肠球菌和6,036株粪肠球菌)进行分析。我们评估了对8种常见抗生素的体外敏感性,并评估了VRE交叉耐药模式。结果:粪肠球菌对氨苄西林、达托霉素、利奈唑胺、替柯planin、替加环素、万古霉素的敏感性均大于95%。相比之下,粪肠杆菌仅对利奈唑胺和替加环素的敏感性大于90%。粪肠杆菌对万古霉素的耐药率为25.4%,显著高于粪肠杆菌(1.22%),且多药交叉耐药显著。从地域上看,北美地区对万古霉素的耐药率最高(53.25%),亚洲地区对利奈唑胺的耐药率最高(2.9%)。ICU和非儿科患者的耐药率普遍较高,泌尿生殖系统标本的耐药率略高于其他部位。结论:肠球菌耐药在不同物种、地区和临床环境中存在显著差异。VRE广泛的交叉耐药给临床治疗带来了重大挑战。替加环素和利奈唑胺在体外全球范围内仍然非常有效。为减缓耐药菌株的传播,在优化抗生素使用策略的同时,加强高风险地区和人群的耐药性监测至关重要。
{"title":"In vitro activity of vancomycin and other commonly used Antibiotics against clinical isolates of Enterococcus faecalis and Enterococcus faecium: Data from the antimicrobial testing leadership and surveillance (ATLAS) program from 2019 to 2023","authors":"Yu Liu ,&nbsp;Xu Zheng ,&nbsp;Binwei Wu","doi":"10.1016/j.jgar.2025.12.018","DOIUrl":"10.1016/j.jgar.2025.12.018","url":null,"abstract":"<div><h3>Objectives</h3><div>Enterococci are significant hospital pathogens, posing a serious global public health threat. This study aimed to analyze the in vitro susceptibility of enterococcal isolates to eight commonly used antibiotics and to explore cross-resistance patterns in vancomycin-resistant enterococci (VRE), including their heterogeneity across geographic regions, clinical wards, and infection sites.</div></div><div><h3>Methods</h3><div>Utilizing data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program (2019–2023), this study analyzed 18,043 enterococcal isolates (12,007 <em>Enterococcus faecalis</em> and 6,036 <em>Enterococcus faecium</em>) from 59 countries across six continents. We assessed in vitro susceptibility to eight common antibiotics and evaluated VRE cross-resistance patterns.</div></div><div><h3>Results</h3><div><em>: E. faecalis</em> showed susceptibility rates greater than 95% to ampicillin, daptomycin, linezolid, teicoplanin, tigecycline, and vancomycin. In contrast, <em>E. faecium</em> exhibited susceptibility greater than 90% only for linezolid and tigecycline. The vancomycin resistance rate in <em>E. faecium</em> was 25.4%, significantly higher than in <em>E. faecalis</em> (1.22%), with notable multidrug cross-resistance. Geographically, North America displayed the highest vancomycin resistance rate in <em>E. faecium</em> (53.25%), while Asia showed the highest linezolid resistance rate in this species (2.9%). ICU and non-pediatric patients generally exhibited higher resistance rates, and genitourinary specimens showed slightly higher resistance than those from other sites.</div></div><div><h3>Conclusions</h3><div>Enterococcal resistance varies significantly across species, regions, and clinical environments. The extensive cross-resistance in VRE poses a major challenge to clinical treatment. Tigecycline and linezolid remain highly effective in vitro globally. To slow the spread of resistant strains, it is crucial to enhance resistance monitoring in high-risk regions and populations, while optimizing antibiotic usage strategies.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"46 ","pages":"Pages 254-263"},"PeriodicalIF":3.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145905990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emergence of blaKPC-71 variant and loss of aerobactin-encoding genes (iucABCD-iutA) in ST11-K64 carbapenem-resistant Klebsiella pneumoniae during ceftazidime–avibactam treatment 在头孢他啶-阿维巴坦治疗期间,ST11-K64耐碳青霉烯肺炎克雷伯菌中出现blaKPC-71变异和易动蛋白编码基因(iucABCD-iutA)的丢失
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-01 DOI: 10.1016/j.jgar.2025.11.020
Fang-ling Du , Dan-dan Wei , Yong-qing Guo , Peng Liu , Yan-fang Mei , Shan-shan Huang , Qi-sen Huang , Lin-Ping Fan , Yang Liu

Objective

To investigate the within-host evolutionary dynamics of resistance and virulence in carbapenem-resistant Klebsiella pneumoniae during ceftazidime-avibactam treatment.

Methods

Three K. pneumoniae strains were isolated from the sputum of the same patient. Broth microdilution method, whole-genome sequencing and genetic analysis were employed to clarify the dynamics and mechanisms of antibiotic resistance. Galleria mellonella infection models were used to investigate the changes in virulence.

Results

The study described the changes of three strains of ST11-K64 carbapenem-resistant K. pneumoniae associated with pulmonary infection in vivo. The transition from a ceftazidime-avibactam-susceptible but imipenem-resistant isolate (JXZRKP1) to a ceftazidime-avibactam-resistant but imipenem-susceptible isolate (JXZRKP2) was attributed to the transformation of the blaKPC gene from blaKPC-2 to blaKPC-71 and upregulation of blaKPC gene expression. Notably, the blaKPC-71 enzyme exhibited a Ser182 duplication compared to the wild-type blaKPC-2 carbapenemase. The blaKPC gene of three strains was carried by the IS26-mediated tandem core structure ISKpn27-blaKPC-IS1182 on an IncFII-type plasmid. Furthermore, in comparison with JXZRKP2, the virulence plasmid of JXZRKP3 lost the aerobactin-encoding genes (iucABCD-iutA), resulting in diminished virulence in G. mellonella infection models, but there was no significant difference(P > .05).

Conclusions

We first discovered that the mutation from blaKPC-2 to blaKPC-71 leads to resistance to ceftazidime-avibactam, followed by the loss of the aerobactin-encoding gene (iucABCD-iutA) on the virulence plasmid in vivo. This study underscores the complexity of addressing carbapenem-resistant K. pneumoniae infections.
目的:研究头孢他啶-阿维巴坦治疗期间耐碳青霉烯肺炎克雷伯菌在宿主内的耐药性和毒力进化动力学。方法:从同一患者的痰液中分离出3株肺炎克雷伯菌。采用微量肉汤稀释法、全基因组测序(WGS)和遗传分析阐明了抗生素耐药的动态和机制。采用大孔线虫感染模型研究其毒力变化。结果:本研究描述了3株ST11-K64耐碳青霉烯类肺炎克雷伯菌体内相关肺部感染的变化。从头孢他啶-阿维巴坦敏感但亚胺培南耐药的分离株(JXZRKP1)到头孢他啶-阿维巴坦耐药但亚胺培南敏感的分离株(JXZRKP2)的转变归因于blaKPC基因从blaKPC-2转化为blaKPC-71,并上调了blaKPC基因的表达。值得注意的是,与野生型blaKPC-2碳青霉烯酶相比,blaKPC-71酶表现出Ser182重复。三个菌株的blaKPC基因由is26介导的串联核心结构ISKpn27-blaKPC-IS1182在incfii型质粒上携带。此外,与JXZRKP2相比,JXZRKP3的毒力质粒丢失了需氧肌动蛋白编码基因(iucABCD-iutA),导致在mellonella感染模型中的毒力降低,但差异无统计学意义(P < 0.05)。结论:我们首先发现从blaKPC-2到blaKPC-71突变导致对头孢他啶-阿维巴坦耐药,随后在体内发现毒质粒上的好氧肌动蛋白编码基因(iucABCD-iutA)缺失。这项研究强调了解决耐碳青霉烯肺炎克雷伯菌感染的复杂性。
{"title":"Emergence of blaKPC-71 variant and loss of aerobactin-encoding genes (iucABCD-iutA) in ST11-K64 carbapenem-resistant Klebsiella pneumoniae during ceftazidime–avibactam treatment","authors":"Fang-ling Du ,&nbsp;Dan-dan Wei ,&nbsp;Yong-qing Guo ,&nbsp;Peng Liu ,&nbsp;Yan-fang Mei ,&nbsp;Shan-shan Huang ,&nbsp;Qi-sen Huang ,&nbsp;Lin-Ping Fan ,&nbsp;Yang Liu","doi":"10.1016/j.jgar.2025.11.020","DOIUrl":"10.1016/j.jgar.2025.11.020","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate the within-host evolutionary dynamics of resistance and virulence in carbapenem-resistant <em>Klebsiella pneumoniae</em> during ceftazidime-avibactam treatment.</div></div><div><h3>Methods</h3><div>Three <em>K. pneumoniae</em> strains were isolated from the sputum of the same patient. Broth microdilution method, whole-genome sequencing and genetic analysis were employed to clarify the dynamics and mechanisms of antibiotic resistance. <em>Galleria mellonella</em> infection models were used to investigate the changes in virulence.</div></div><div><h3>Results</h3><div>The study described the changes of three strains of ST11-K64 carbapenem-resistant <em>K. pneumoniae</em> associated with pulmonary infection in vivo. The transition from a ceftazidime-avibactam-susceptible but imipenem-resistant isolate (JXZRKP1) to a ceftazidime-avibactam-resistant but imipenem-susceptible isolate (JXZRKP2) was attributed to the transformation of the <em>bla</em><sub>KPC</sub> gene from <em>bla</em><sub>KPC-2</sub> to <em>bla</em><sub>KPC-71</sub> and upregulation of <em>bla</em><sub>KPC</sub> gene expression. Notably, the <em>bla</em><sub>KPC-71</sub> enzyme exhibited a Ser182 duplication compared to the wild-type <em>bla</em><sub>KPC-2</sub> carbapenemase. The <em>bla</em><sub>KPC</sub> gene of three strains was carried by the IS<em>26</em>-mediated tandem core structure IS<em>Kpn27</em>-<em>bla</em><sub>KPC</sub>-IS<em>1182</em> on an IncFII-type plasmid. Furthermore, in comparison with JXZRKP2, the virulence plasmid of JXZRKP3 lost the aerobactin-encoding genes (<em>iucABCD-iutA</em>), resulting in diminished virulence in <em>G. mellonella</em> infection models, but there was no significant difference(<em>P</em> &gt; .05).</div></div><div><h3>Conclusions</h3><div>We first discovered that the mutation from <em>bla</em><sub>KPC-2</sub> to <em>bla</em><sub>KPC-71</sub> leads to resistance to ceftazidime-avibactam, followed by the loss of the aerobactin-encoding gene (<em>iucABCD-iutA</em>) on the virulence plasmid in vivo. This study underscores the complexity of addressing carbapenem-resistant <em>K. pneumoniae</em> infections.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"46 ","pages":"Pages 166-170"},"PeriodicalIF":3.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145781127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First identification of a multidrug-resistant Pseudomonas kurunegalensis clinical isolate co-carrying blaAFM-1 and blaIMP-1 in China 中国首次发现一株多重耐药库鲁egalensis假单胞菌临床分离株共携带blaAFM-1和blaIMP-1。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-01 DOI: 10.1016/j.jgar.2025.12.007
Shuwei Fan , Yuzhuo Gong , Chunxiao Chen , Jingchao Shi , Cong Wu

Objectives

The objective of this study was to elucidate the genetic context and characterize chromosome co-carrying blaAFM-1 and blaIMP-1 in a multidrug-resistant Pseudomonas kurunegalensis (P. kurunegalensis) isolate obtained from human urine using whole-genome sequencing.

Methods

This P. kurunegalensis isolate JC172 co-harbouring blaAFM-1 and blaIMP-1 underwent a comprehensive investigation that included antimicrobial susceptibility testing, conjugation assays, whole-genome sequencing and bioinformatic analyses. To depict the evolutionary dynamics of P. kurunegalensis strains on a global scale, a phylogenetic tree was generated based on single nucleotide polymorphisms of core genomes.

Results

JC172 was classified as P. kurunegalensis based on sequencing results and average nucleotide identity (ANI) assessments. This isolate was designated as ST114 and possesses a chromosome with 5 855 340 base pairs, exhibiting a GC content of 61.9%. Several resistance genes, including blaAFM-1 and blaIMP-1, blaOXA-246 and tmexC3D2-toprJ1 were identified on the chromosome. Genomic analysis revealed that blaAFM-1 was situated within a core module of the TnAs3-blaAFM-1 unit, which is bordered by class 1 integrons. This arrangement implies a significant potential for blaAFM-1 dissemination.

Conclusions

Our study revealed that blaAFM-1 and blaIMP-1, blaOXA-246 and tmexC3D2-toprJ1 were harboured by P. kurunegalensis. We suggested that ST114 P. kurunegalensis may serve as a reservoir for resistance genes.
目的:本研究的目的是利用全基因组测序技术,阐明从人类尿液中获得的多重耐药kurunegalensis假单胞菌(P. kurunegalensis)的遗传背景和染色体共携带blaAFM-1和blaIMP-1的特征。方法:对共携带blaAFM-1和blaIMP-1的kurunegalensis分离株JC172进行药敏试验、偶联试验、全基因组测序和生物信息学分析。为了描述p.k urunegalensis菌株在全球范围内的进化动态,基于核心基因组的单核苷酸多态性构建了系统发育树。结果:根据测序结果和平均核苷酸同源性(ANI)鉴定,JC172属kurunegalensis。该分离物被命名为ST114,具有一条5,855,340对碱基对的染色体,GC含量为61.9%。在染色体上鉴定出blaAFM-1和blaIMP-1、blaOXA-246和tmexc32d - toprj1等抗性基因。基因组分析显示,blaAFM-1位于TnAs3-blaAFM-1单元的核心模块中,该单元与1类整合子相邻。这种安排意味着blaAFM-1传播的巨大潜力。结论:我们的研究表明,blaAFM-1、blaIMP-1、blaOXA-246和tmexc32d - toprj1在库鲁尼加疟原虫中存在。我们认为ST114库鲁egalensis可能是抗性基因的储存库。
{"title":"First identification of a multidrug-resistant Pseudomonas kurunegalensis clinical isolate co-carrying blaAFM-1 and blaIMP-1 in China","authors":"Shuwei Fan ,&nbsp;Yuzhuo Gong ,&nbsp;Chunxiao Chen ,&nbsp;Jingchao Shi ,&nbsp;Cong Wu","doi":"10.1016/j.jgar.2025.12.007","DOIUrl":"10.1016/j.jgar.2025.12.007","url":null,"abstract":"<div><h3>Objectives</h3><div>The objective of this study was to elucidate the genetic context and characterize chromosome co-carrying <em>bla</em><sub>AFM-1</sub> and <em>bla</em><sub>IMP-1</sub> in a multidrug-resistant <em>Pseudomonas kurunegalensis</em> (<em>P. kurunegalensis</em>) isolate obtained from human urine using whole-genome sequencing.</div></div><div><h3>Methods</h3><div>This <em>P. kurunegalensis</em> isolate JC172 co-harbouring <em>bla</em><sub>AFM-1</sub> and <em>bla</em><sub>IMP-1</sub> underwent a comprehensive investigation that included antimicrobial susceptibility testing, conjugation assays, whole-genome sequencing and bioinformatic analyses. To depict the evolutionary dynamics of <em>P. kurunegalensis</em> strains on a global scale, a phylogenetic tree was generated based on single nucleotide polymorphisms of core genomes.</div></div><div><h3>Results</h3><div>JC172 was classified as <em>P. kurunegalensis</em> based on sequencing results and average nucleotide identity (ANI) assessments. This isolate was designated as ST114 and possesses a chromosome with 5 855 340 base pairs, exhibiting a GC content of 61.9%. Several resistance genes, including <em>bla</em><sub>AFM-1</sub> and <em>bla</em><sub>IMP-1</sub>, <em>bla</em><sub>OXA-246</sub> and <em>tmexC3D2-toprJ1</em> were identified on the chromosome. Genomic analysis revealed that <em>bla</em><sub>AFM-1</sub> was situated within a core module of the <em>TnAs3</em>-<em>bla</em><sub>AFM-1</sub> unit, which is bordered by class 1 integrons. This arrangement implies a significant potential for <em>bla</em><sub>AFM-1</sub> dissemination.</div></div><div><h3>Conclusions</h3><div>Our study revealed that <em>bla</em><sub>AFM-1</sub> and <em>bla</em><sub>IMP-1</sub>, <em>bla</em><sub>OXA-246</sub> and <em>tmexC3D2-toprJ1</em> were harboured by <em>P. kurunegalensis</em>. We suggested that ST114 <em>P. kurunegalensis</em> may serve as a reservoir for resistance genes.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"46 ","pages":"Pages 162-165"},"PeriodicalIF":3.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145756847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multicentric evaluation of the MTS™ Synergy Application System for reliable antibiotic synergy testing in clinical laboratories 多中心评价MTS-SAS®在临床实验室可靠的抗生素协同试验。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-01 DOI: 10.1016/j.jgar.2025.12.010
Edoardo Carretto , Stefano Andreoni , Richard Aschbacher , Daniela Barbarini , Simone Bramati , Flavia Brovarone , Claudio Farina , Angela Papa , Andrea Rocchetti , Giuseppe Russello , Vittorio Sambri , Assunta Sartor , Paolo Gaibani

Objectives

The rise of antimicrobial resistance poses a major challenge for both clinicians and clinical microbiologists. There is an increasing need for user-friendly and reliable methods to assess the activity of antibiotics against multidrug-resistant (MDR) strains. Although synergy testing provides valuable insights, conventional methods such as checkerboard assays and time-kill studies are labour-intensive, technically demanding, and difficult to standardize. This study evaluated the MTS™ SAS (MIC Test Strip – Synergy Application System, Liofilchem, Italy), a commercial gradient diffusion assay developed for antibiotic synergy testing.

Methods

The performance of MTS™ SAS was evaluated in comparison with the checkerboard microdilution method, used as the reference standard. Nine antibiotic combinations were tested against ten different bacterial strains across 11 Italian hospitals. Inter-laboratory reproducibility and agreement with the reference method were analysed.

Results

The concordance between MIC test strips and the broth microdilution (BMD) method was 98.4%, with 1.6% showing discordant results – all within a 3-dilution range. Among 996 synergy determinations, MTS™ SAS demonstrated high reproducibility across all centers (96.7%), while only 3.3% of tests showed discordant synergy classifications (e.g., synergy vs. indifference). Comparison with the checkerboard method demonstrated an overall concordance of 96.2%, despite the absence of specific operator training at each site.

Conclusion

These findings support MTS™ SAS as a practical and reliable alternative to conventional synergy testing methods, particularly suitable for routine clinical settings and laboratories lacking advanced microbiological expertise.
目的:抗菌素耐药性的上升对临床医生和临床微生物学家提出了重大挑战。越来越需要用户友好和可靠的方法来评估抗生素对多药耐药菌株的活性。尽管协同测试提供了有价值的见解,但诸如棋盘分析和耗时研究之类的传统方法是劳动密集型的,技术要求高,并且难以标准化。本研究评估了MTS-SAS®(MIC试纸-协同应用系统,Liofilchem®,意大利),这是一种用于抗生素协同测试的商业梯度扩散试验。方法:将MTS-SAS®与棋盘格微量稀释法进行比较,并作为对照标准。在意大利11家医院对9种抗生素组合进行了针对10种不同菌株的测试。分析了该方法的实验室间重复性及与参考方法的一致性。结果:MIC试纸与微量肉汤稀释法(BMD)的一致性为98.4%,结果不一致的为1.6%,均在3倍稀释范围内。在996个协同作用测定中,MTS-SAS®在所有中心显示出高重复性(96.7%),而只有3.3%的试验显示出不一致的协同作用分类(例如,协同作用与无差异)。与棋盘法相比,尽管在每个站点缺乏具体的操作人员培训,但总体一致性为96.2%。结论:这些发现支持MTS-SAS®作为传统协同检测方法的实用可靠的替代方法,特别适用于常规临床环境和缺乏先进微生物专业知识的实验室。
{"title":"Multicentric evaluation of the MTS™ Synergy Application System for reliable antibiotic synergy testing in clinical laboratories","authors":"Edoardo Carretto ,&nbsp;Stefano Andreoni ,&nbsp;Richard Aschbacher ,&nbsp;Daniela Barbarini ,&nbsp;Simone Bramati ,&nbsp;Flavia Brovarone ,&nbsp;Claudio Farina ,&nbsp;Angela Papa ,&nbsp;Andrea Rocchetti ,&nbsp;Giuseppe Russello ,&nbsp;Vittorio Sambri ,&nbsp;Assunta Sartor ,&nbsp;Paolo Gaibani","doi":"10.1016/j.jgar.2025.12.010","DOIUrl":"10.1016/j.jgar.2025.12.010","url":null,"abstract":"<div><h3>Objectives</h3><div>The rise of antimicrobial resistance poses a major challenge for both clinicians and clinical microbiologists. There is an increasing need for user-friendly and reliable methods to assess the activity of antibiotics against multidrug-resistant (MDR) strains. Although synergy testing provides valuable insights, conventional methods such as checkerboard assays and time-kill studies are labour-intensive, technically demanding, and difficult to standardize. This study evaluated the MTS™ SAS (MIC Test Strip – Synergy Application System, Liofilchem, Italy), a commercial gradient diffusion assay developed for antibiotic synergy testing.</div></div><div><h3>Methods</h3><div>The performance of MTS™ SAS was evaluated in comparison with the checkerboard microdilution method, used as the reference standard. Nine antibiotic combinations were tested against ten different bacterial strains across 11 Italian hospitals. Inter-laboratory reproducibility and agreement with the reference method were analysed.</div></div><div><h3>Results</h3><div>The concordance between MIC test strips and the broth microdilution (BMD) method was 98.4%, with 1.6% showing discordant results – all within a 3-dilution range. Among 996 synergy determinations, MTS™ SAS demonstrated high reproducibility across all centers (96.7%), while only 3.3% of tests showed discordant synergy classifications (e.g., synergy vs. indifference). Comparison with the checkerboard method demonstrated an overall concordance of 96.2%, despite the absence of specific operator training at each site.</div></div><div><h3>Conclusion</h3><div>These findings support MTS™ SAS as a practical and reliable alternative to conventional synergy testing methods, particularly suitable for routine clinical settings and laboratories lacking advanced microbiological expertise.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"46 ","pages":"Pages 209-213"},"PeriodicalIF":3.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145804298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genomic and phylogenetic analysis of a carbapenem-resistant Raoultella ornithinolytica clinical isolate carrying blaOXA-181 from China 中国携带blaOXA-181的耐碳青霉烯型溶鸟拉乌尔菌临床分离株的基因组和系统发育分析
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-12-02 DOI: 10.1016/j.jgar.2025.11.019
Zhiqiang Zhu , Xiaofei Zhao , Zhaokun Fan , Ying Fu , Xi Li , Meizhen Ye

Objective

Raoultella ornithinolytica, a species within Enterobacteriaceae, is rarely multidrug-resistant. Here, we report a carbapenem-resistant R. ornithinolytica carrying blaOXA-181 and elucidate its genomic characteristics for the first time in China.

Methods

Antimicrobial susceptibility testing and hybrid whole-genome sequencing were conducted on the R. ornithinolytica strain CRRAO31010. Comprehensive in silico analyses of virulence determinants, resistance genes, and their genetic contexts were performed. Conjugation experiments were conducted with Escherichia coli J53 as the recipient to assess the transferability of blaOXA-181. In addition, we combined our isolate with 56 R. ornithinolytica strains bearing the blaOXA-181 gene retrieved from the NCBI database for phylogenetic analysis.

Results

R. ornithinolytica strain CRRAO31010 is a carbapenem-resistant strain characterized by its production of the OXA-181 enzyme, which confers resistance to multiple antibiotics. WGS revealed 22 antimicrobial resistance genes in CRRAO31010, including blaOXA-181 carried on a ColKP3-IncX3 hybrid plasmid. This plasmid was conjugated into E. coli J53 with a conjugation frequency of approximately 2.5 × 10−6 per donor cell. Phylogenetic analysis revealed that the earliest R. ornithinolytica strain carrying the blaOXA-181 gene was detected in the United Kingdom in 2019. The United States had the highest number of OXA-181-carrying R. ornithinolytica strains. Notably, IncX3-type plasmids had the highest prevalence (96.49%, 55/57) among these isolates.

Conclusions

We report the first carbapenem-resistant R. ornithinolytica strain harbouring the blaOXA-181 gene on a ColKP3-IncX3 hybrid plasmid from China. Given the high conjugative potential of IncX3 plasmids, vigilance is required to monitor the dissemination of such resistance determinants within R. ornithinolytica.
目的:溶鸟拉乌尔菌是肠杆菌科的一种罕见的多重耐药菌。本文报道了一株携带blaOXA-181的耐碳青霉烯型溶鸟盲蝽,并在国内首次阐明了其基因组特征。方法:对溶鸟毒R. CRRAO31010进行药敏试验和杂交全基因组测序。对毒力决定因素、抗性基因及其遗传背景进行了全面的计算机分析。以大肠杆菌J53为受体进行偶联实验,评估blaOXA-181的可移植性。此外,我们将分离物与从NCBI数据库中检索到的56株携带blaOXA-181基因的溶鸟单胞菌进行系统发育分析。结果:鸟毒R. ornithinolytica菌株CRRAO31010是一株碳青霉烯耐药菌株,其特征是产生OXA-181酶,对多种抗生素具有耐药性。WGS在CRRAO31010中发现22个耐药基因,其中包括ColKP3-IncX3杂交质粒上携带的blaOXA-181。该质粒被偶联到大肠杆菌J53中,偶联频率约为2.5×10-6 /供体细胞。系统发育分析显示,最早携带blaOXA-181基因的禽毒r于2019年在英国检测到。美国携带oxa -181的禽毒r菌株数量最多。其中,incx3型质粒的感染率最高(96.49%,55/57)。结论:在中国ColKP3-IncX3杂交质粒上发现了首株含有blaOXA-181基因的耐碳青霉烯型溶鸟单胞菌。考虑到IncX3质粒的高结合潜力,需要警惕地监测这些耐药决定因素在溶鸟盲蝽体内的传播。
{"title":"Genomic and phylogenetic analysis of a carbapenem-resistant Raoultella ornithinolytica clinical isolate carrying blaOXA-181 from China","authors":"Zhiqiang Zhu ,&nbsp;Xiaofei Zhao ,&nbsp;Zhaokun Fan ,&nbsp;Ying Fu ,&nbsp;Xi Li ,&nbsp;Meizhen Ye","doi":"10.1016/j.jgar.2025.11.019","DOIUrl":"10.1016/j.jgar.2025.11.019","url":null,"abstract":"<div><h3>Objective</h3><div><em>Raoultella ornithinolytica</em>, a species within <em>Enterobacteriaceae</em>, is rarely multidrug-resistant. Here, we report a carbapenem-resistant <em>R. ornithinolytica</em> carrying <em>bla</em><sub>OXA-181</sub> and elucidate its genomic characteristics for the first time in China.</div></div><div><h3>Methods</h3><div>Antimicrobial susceptibility testing and hybrid whole-genome sequencing were conducted on the <em>R. ornithinolytica</em> strain CRRAO31010. Comprehensive in silico analyses of virulence determinants, resistance genes, and their genetic contexts were performed. Conjugation experiments were conducted with <em>Escherichia coli</em> J53 as the recipient to assess the transferability of <em>bla</em><sub>OXA-181</sub>. In addition, we combined our isolate with 56 <em>R. ornithinolytica</em> strains bearing the <em>bla</em><sub>OXA-181</sub> gene retrieved from the NCBI database for phylogenetic analysis.</div></div><div><h3>Results</h3><div><em>R. ornithinolytica</em> strain CRRAO31010 is a carbapenem-resistant strain characterized by its production of the OXA-181 enzyme, which confers resistance to multiple antibiotics. WGS revealed 22 antimicrobial resistance genes in CRRAO31010, including <em>bla</em><sub>OXA-181</sub> carried on a ColKP3-IncX3 hybrid plasmid. This plasmid was conjugated into <em>E. coli</em> J53 with a conjugation frequency of approximately 2.5 × 10<sup>−6</sup> per donor cell. Phylogenetic analysis revealed that the earliest <em>R. ornithinolytica</em> strain carrying the <em>bla</em><sub>OXA-181</sub> gene was detected in the United Kingdom in 2019. The United States had the highest number of OXA-181-carrying <em>R. ornithinolytica strains</em>. Notably, IncX3-type plasmids had the highest prevalence (96.49%, 55/57) among these isolates.</div></div><div><h3>Conclusions</h3><div>We report the first carbapenem-resistant <em>R. ornithinolytica</em> strain harbouring the <em>bla</em><sub>OXA-181</sub> gene on a ColKP3-IncX3 hybrid plasmid from China. Given the high conjugative potential of IncX3 plasmids, vigilance is required to monitor the dissemination of such resistance determinants within <em>R. ornithinolytica</em>.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"46 ","pages":"Pages 128-131"},"PeriodicalIF":3.2,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145668726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of global antimicrobial resistance
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1